Analysts at Piper Jaffray downgrade Allscripts Healthcare Solutions Inc MDRX from “overweight” to “neutral.” The target price for MDRX is set to $22.
MDRX shares fell 1.78% to close at $21.58 yesterday.
More Analyst Ratings here
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
